(Credit: Rahul Sidhu on Shutterstock)
In A Nutshell
- Scientists reprogrammed skin cells from children with Sanfilippo syndrome into lab-grown brain cells and found a critical flaw in how those cells communicate with each other.
- Individual brain cells looked and fired normally, but when connected in networks, excitatory signals far outpaced inhibitory ones, tipping the brain into a state of chronic overactivity.
- Sanfilippo brain networks showed twice the synchronized firing of healthy networks, a pattern linked to overactive signaling seen in other neurological conditions.
- Pinpointing overactive excitatory connections as a driver could help guide future drug strategies to ease symptoms, even in children diagnosed too late for gene therapy.
A child who seems perfectly healthy at birth learns to walk and talk on schedule, then slowly starts losing those abilities, forgetting words, struggling to move, eventually unable to recognize their own parents. That’s Sanfilippo syndrome, a form of childhood dementia, a group of rare genetic diseases that progressively destroys the brain. Many children with this condition die in early adolescence, and until now, scientists had limited understanding of what was going wrong at the level of brain cell communication.
New research has changed that. Scientists reprogrammed skin cells from five children with Sanfilippo syndrome Type A into functioning brain cells, building miniature patient brain circuits in a dish. Individual nerve cells looked normal, fired normally, and grew normally. But when those cells began communicating with each other, something went wrong. Excitatory signals, the ones that tell brain cells to fire, were significantly elevated, while inhibitory signals, the ones that say calm down, lagged far behind. Networks of these cells showed twice the synchronized firing of networks grown from healthy children.
That imbalance is a pattern seen across a range of brain conditions involving overactive signaling, but this is one of the clearest demonstrations to date in childhood dementia using cells from actual patients. It points toward a specific, targetable problem: hyperactive connections between brain cells, a finding that could open the door to drug treatments aimed at easing cognitive symptoms, even in children diagnosed too late for gene therapy.
How Researchers Built Childhood Dementia Brain Cells in a Dish
A team led by scientists at the South Australian Health and Medical Research Institute and Flinders University collected skin samples from five children with Sanfilippo syndrome Type A and five age-matched typical donors. Those skin cells were reprogrammed to a stem-cell-like state and guided into the type of brain cells responsible for higher thinking, then grown for up to 120 days to form communicating networks.
To strengthen reliability, the team developed what they called a “playground” model, a nod to the children who donated their cells, mixing multiple patient cell lines together before analysis. Nearly 1,000 individual brain cells were recorded for electrical activity, more than 5,000 electrodes monitored across 323 wells over three months, and more than 2.5 million neurons imaged using high-powered microscopy.
Normal Cells, Abnormal Conversations
Before examining how cells communicated, the team confirmed the disease cells weren’t fundamentally defective on their own. Sanfilippo brain cells expressed the right identity markers, developed normal branching structures, and were virtually indistinguishable from typical neurons on nearly every individual measure. As the paper summarizes, “Altogether, our findings indicate that MPS IIIA pathophysiology does not directly affect the firing capabilities or the membrane potential properties of the neurons and, therefore, is not likely to be an underlying cause of impaired neural communication and cognition.”
Problems emerged at the synapses, the junctions where brain cells pass chemical signals to one another. From 30 days of growth onward, Sanfilippo cultures showed significantly more excitatory connections than typical cultures. Inhibitory connections developed more slowly and were significantly fewer by 90 days.
A Childhood Dementia Brain Out of Balance
Electrical recordings confirmed it. At 90 to 120 days, excitatory signals in Sanfilippo cells fired at roughly double the frequency of those in typical cells and at significantly greater strength. Inhibitory signals showed no comparable increase. Even when researchers blocked all electrical activity with a drug to isolate only the smallest spontaneous synaptic events, the same pattern held.
At the network level, individual Sanfilippo cells fired at normal rates, but networks as a whole were hyperactive, with significantly more active and bursting cells and twice the frequency of synchronized firing events. When mild cellular stress was applied by temporarily removing growth-supporting factors from the culture medium, typical cells were unaffected. In Sanfilippo cultures, that same mild stress amplified excess excitatory connections by more than 40 percent.
Published in Nature Communications, the study also found that genes tied to excitatory synapse structure and function were significantly more active in Sanfilippo brain cells, while genes governing inhibitory connections showed no corresponding changes.
Why This Childhood Dementia Discovery Could Change Treatment
Gene and enzyme replacement therapies, currently the most promising options for Sanfilippo syndrome, work best in children under 30 months old. Diagnosis rarely happens that early, and even if such therapies gain approval, they will remain expensive and geographically limited. A drug targeting overactive excitatory signaling might one day help improve quality of life regardless of when a child is diagnosed.
Sanfilippo syndrome doesn’t produce brain cells that look wrong, grow wrong, or fire wrong on their own. It corrupts the communication between them, subtly at first, then catastrophically as networks mature. For families watching a child lose the ability to think, speak, and move, that distinction matters. If the problem lies in how brain cells talk to each other rather than in the cells themselves, that’s a target medicine might actually be able to reach.
Disclaimer: This study was conducted using lab-grown brain cells derived from a small number of patients and has not been tested as a treatment in humans. Findings represent early-stage laboratory research and should not be interpreted as medical advice or a clinical recommendation.
Paper Notes
Limitations
This study used cells grown in a laboratory dish, which cannot fully replicate a living human brain. Cultures lacked the full diversity of cell types and three-dimensional architecture found in actual brain tissue. One cell line per patient was analyzed for electrical recording in most cases, and a growth period of 120 days, while lengthy for cell culture, represents only a fraction of real human brain development. Five patients and five typical donors, though generating large data volumes, represent a limited range of genetic backgrounds.
Funding and Disclosures
Funding sources include the Australian Medical Research Future Fund Accelerated Research Program, the Sanfilippo Children’s Foundation, the Australian Medical Research Future Fund Stem Cell Therapies Mission, Boileau Corporate Philanthropy, and the Grosset Gaya Fund. Cedric Bardy holds an Australian Research Council Future Fellowship, an affiliation with Brain Organoid Therapeutics in Adelaide, Australia, and is an inventor on the BrainPhys patent. Several co-authors hold advisory or leadership roles with the Sanfilippo Children’s Foundation, the Childhood Dementia Initiative, and the Cure Sanfilippo Foundation.
Publication Details
Title: Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks | Authors: Paris Mazzachi, Ella McDonald, Zarina Greenberg, Alejandra Noreña Puerta, Jenne Tran, Manam Inushi De Silva, Cade Christensen, Robert Adams, Sebastian Loskarn, Helen Beard, Michael Zabolocki, Meera Elmasri, Megan Maack, Kristina L. Elvidge, Mark R. Hutchinson, Cara O’Neill, Kim M. Hemsley, Lisa Melton, Nicholas Smith, and Cedric Bardy. Paris Mazzachi, Ella McDonald, and Zarina Greenberg contributed equally as co-first authors. | Journal: Nature Communications (2026), 17:3161 | DOI: https://doi.org/10.1038/s41467-026-71112-9 | Corresponding author: Cedric Bardy







